Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

LL-37

Cathelicidin, hCAP-18, FALL-39, CAP-18

Quick Stats
Studies 2230
Trials 95
Score 3
2014 pubmed 45 citations

Regulation of the human cathelicidin antimicrobial peptide gene by 1α,25-dihydroxyvitamin D3 in primary immune cells.

Lowry. Malcolm B MB; Guo. Chunxiao C; Borregaard. Niels N; Gombart. Adrian F AF

Key Findings

  • LL‑37 is low in lymphocytes, medium in monocytes, and highest in neutrophils.
  • Active vitamin D (1,25‑dihydroxyvitamin D3) strongly induces LL‑37 expression in macrophages and also raises it in dendritic cells and osteoclasts.
  • Combining parathyroid hormone with vitamin D does not further increase LL‑37 in immune cells.

Practical Outcomes

  • Ensuring adequate active vitamin D status may boost the antimicrobial peptide LL‑37, potentially enhancing infection resistance. Biohackers can focus on vitamin D supplementation without needing additional hormones. However, specific dosing and clinical outcomes remain to be clarified.

Summary

The study shows that the immune‑boosting peptide LL‑37 is naturally higher in neutrophils and can be dramatically increased by the active form of vitamin D, especially in macrophages and dendritic cells, while adding parathyroid hormone doesn’t help. This suggests that getting enough active vitamin D could raise LL‑37 levels and improve innate immunity, but the research doesn’t give exact dosing guidance.

Abstract

Production of the human cathelicidin antimicrobial peptide gene (hCAP18/LL-37), is regulated by 1α,25-dihydroxyvitamin D3 (1,25D3) and is critical in the killing of pathogens by innate immune cells. In addition, secreted LL-37 binds extracellular receptors and modulates the recruitment and activity of both innate and adaptive immune cells. Evidence suggests that during infections activated immune cells locally produce increased levels of 1,25D3 thus increasing production of hCAP18/LL-37. The relative expression levels of hCAP18/LL-37 among different immune cell types are not well characterized. The aim of this study was to determine the relative levels of hCAP18/LL-37 in human peripheral blood immune cells and determine to what extent 1,25D3 increased its expression in peripheral blood-derived cells. We show for the first time, a hierarchy of expression of hCAP18 in freshly isolated cells with low levels in lymphocytes, intermediate levels in monocytes and the highest levels found in neutrophils. In peripheral blood-derived cells, the highest levels of hCAP18 following treatment with 1,25D3 were in macrophages, while comparatively lower levels were found in GM-CSF-derived dendritic cells and osteoclasts. We also tested whether treatment with parathyroid hormone in combination with 1,25D3 would enhance hCAP18 induction as has been reported in skin cells, but we did not find enhancement in any immune cells tested. Our results indicate that hCAP18 is expressed at different levels according to cell type and lineage. Furthermore, potent induction of hCAP18 by 1,25D3 in macrophages and dendritic cells may modulate functions of both innate and adaptive immune cells at sites of infection.

Study Information

Provider

pubmed

Year

2014

Date

2014-02-22T00:00:00.000Z

DOI

10.1016/j.jsbmb.2014.02.004

Citations

45

References

52